Vico: The new layout continues to add code in this area of the future can not be underestimated.

On October 21st, Vico Orthopaedics and Step Robot signed a strategic cooperation agreement, which will strengthen cooperation in brand promotion, product sales, resource sharing, joint research and development, etc.
Robotics is a technology company focused on rehabilitation of exoskeleton robots and human-computer interaction technology.
years, Vico Orthopaedics is committed to the development of domestic surgical robots, to overcome key core technologies, to the international cutting-edge technology field.
this collaboration is also an important layout of Vico Orthopaedics in the field of medical robots.
Weigao Orthopaedics was established in 2005, focusing on the field of orthopaedic medical devices, the main business for orthopaedic medical devices research and development, production and sales, the main products include orthopaedic implanted medical devices and orthopaedic surgical instruments tools, is one of the first to enter the field of high-end implanted orthopaedic medical devices manufacturers, has developed into the domestic orthopaedic field leading enterprises.
strong rise of the domestic orthopaedic industry strength first, product line full and strong in 2019, Vico orthopaedics with 5.12% market share, ranked 4th in the field of orthopaedic implant medical devices, is the only domestic manufacturers into the top 5, while the overall market share ranked first in domestic manufacturers, enough to see its strong strength.
2019, China's orthopaedic implant market share ranking Weigao Orthopaedics is the most complete domestic product line of companies, products covering trauma, spine and joints and other categories, and have strong competitiveness.
industry's main competitive company product line layout Weigao product line is not only complete, and are ranked high, spine products market share ranked first in domestic manufacturers, the industry's third, trauma products market share ranked second in domestic manufacturers, the industry's fifth, joint products market share ranked third in domestic manufacturers, the industry's seventh.
1, spine market: domestic absolute leader.
2019, The revenue of Weigao Orthopaedic Spine Products was 770 million yuan, up 26.71% YoY.
market share reached 7.92%, in the domestic spine market, Vico orthopaedics has achieved the first domestic enterprises, second only to Johnson and Johnson and Medtron, there is room for further improvement in the future.
2, Trauma Market: The market size is expected to further increase.
2019, the company's Viccor orthopaedic trauma products revenue of 442 million yuan, an increase of 28.7% year-on-year.
market share of 4.66 percent, ranking fifth among all manufacturers and second among domestic manufacturers.
3, joint market: accelerated layout.
2019, Vico Orthopaedics has a domestic market share of 3.53%, ranking seventh among all manufacturers and third among domestic manufacturers.
the company's strong orthopaedic sales channels, joint market share is expected to continue to improve.
layout of the future continue to increase investment in research and development, cut into the field of medical robots after the Yangtze River wave forward, the front wave only continuous investment in research and development will not be eliminated.
as the industry leader, "Vico Orthopaedics" for many years continued to focus on technology and product innovation and development, adhere to the continuous updating of products iteration.
investment in research and development, the investment expenses of Vico orthopaedics in 2017-2019 were RMB37.7814 million, RMB48.0604 million and RMB74.0911 million, respectively, accounting for 4.17%, 3.97% and 4.71% of operating income, respectively.
in the patent, the current Vico orthopaedics has 199 patents, of which 42 invention patents, three types of medical device registration certificate 80, is the industry's domestic brands have the largest number of registered companies.
company is currently researching orthopaedics projects in addition to the above-mentioned orthopaedic research projects, Vico Group will be intelligent products as the focus area of the future, set up a special robotics company, dedicated to the development of domestic surgical robots, in the field of minimally invascopic surgical robots and magnetic navigation robots, greatly enhance the level of domestic robotics technology.
Among them, Weigao's "magic hand" surgical robot is a new generation of robot surgical system developed by China, which has made a major breakthrough in the mechanical design of robot system, master-to-master control, stereoscopic image and system integration, and has been used by Vigo as a strategic weapon to break the monopoly of the "Da Vinci surgical robot" industry in the United States.
It is worth mentioning that in September this year, Professor Niu Haitao, Vice Dean of Qingdao University Hospital, led the team to successfully carry out the "magic hand robot" auxiliary urology surgery, for patients nearly 3000 kilometers away from the bladder root surgery, this is the first time the magic hand robot for patients ultra-remote urological surgery, marking a solid step forward in the industrialization of the product.
in the medical industry, with a first-come-first advantage of the industry leader, usually with a very high industry acumen.
such enterprises can quickly catch the trend of industry development, their strategic layout to a large extent, but also represents the future of the industry's golden opportunities.
as a big man in the field of domestic orthopaedics, the layout of medical robots, once again proved that the field can not be ignored the huge industry prospects.
With the continuous deepening of the integration of technology and modern clinical medicine, the introduction of good policies, the field of medical robots will usher in the spring of development, I believe that Vico orthopaedics by virtue of its own technology, market advantages will also be expected to achieve the international giant beyond!